Northern Trust Corp Xenon Pharmaceuticals Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Northern Trust Corp holds 43,406 shares of XENE stock, worth $1.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,406

Previous 46,852 7.36%

Holding current value

$1.69 Million

Previous $1.83 Million 6.46%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$36.12 - $43.96 $124,469 - $151,486	-3,446 Reduced 7.36%	43,406 $1.71 Million
Q2 2024 Aug 14, 2024	SELL	$36.25 - $43.75 $58,652 - $70,787	-1,618 Reduced 3.34%	46,852 $1.83 Million
Q1 2024 May 14, 2024	SELL	$42.66 - $50.04 $575,952 - $675,590	-13,501 Reduced 21.79%	48,470 $2.09 Million
Q4 2023 Feb 13, 2024	SELL	$28.7 - $46.46 $206,525 - $334,326	-7,196 Reduced 10.4%	61,971 $2.85 Million
Q3 2023 Nov 13, 2023	BUY	$34.16 - $39.73 $125,845 - $146,365	3,684 Added 5.63%	69,167 $2.36 Million
Q2 2023 Aug 11, 2023	BUY	$34.84 - $43.54 $156,083 - $195,059	4,480 Added 7.34%	65,483 $2.52 Million
Q1 2023 May 15, 2023	BUY	$33.46 - $40.35 $26,299 - $31,715	786 Added 1.31%	61,003 $2.18 Million
Q4 2022 Feb 13, 2023	BUY	$33.06 - $39.43 $308,317 - $367,724	9,326 Added 18.33%	60,217 $2.37 Million
Q3 2022 Nov 14, 2022	BUY	$30.79 - $39.82 $89,137 - $115,278	2,895 Added 6.03%	50,891 $1.84 Million
Q2 2022 Aug 12, 2022	BUY	$25.44 - $35.16 $81,916 - $113,215	3,220 Added 7.19%	47,996 $1.46 Million
Q1 2022 May 13, 2022	SELL	$25.09 - $33.13 $146,023 - $192,816	-5,820 Reduced 11.5%	44,776 $1.37 Million
Q4 2021 Feb 08, 2022	BUY	$15.6 - $35.4 $198,837 - $451,208	12,746 Added 33.68%	50,596 $1.58 Million
Q3 2021 Nov 15, 2021	SELL	$14.86 - $19.45 $102,103 - $133,640	-6,871 Reduced 15.36%	37,850 $579,000
Q2 2021 Aug 13, 2021	SELL	$16.81 - $20.0 $98,187 - $116,820	-5,841 Reduced 11.55%	44,721 $832,000
Q1 2021 May 12, 2021	BUY	$13.65 - $21.31 $53,781 - $83,961	3,940 Added 8.45%	50,562 $904,000
Q4 2020 Feb 11, 2021	SELL	$9.49 - $16.04 $149,287 - $252,325	-15,731 Reduced 25.23%	46,622 $717,000
Q3 2020 Nov 16, 2020	BUY	$10.82 - $13.35 $7,768 - $9,585	718 Added 1.16%	62,353 $690,000
Q2 2020 Aug 14, 2020	BUY	$10.21 - $14.9 $30,997 - $45,236	3,036 Added 5.18%	61,635 $772,000
Q1 2020 May 14, 2020	BUY	$8.08 - $17.57 $116,804 - $253,991	14,456 Added 32.75%	58,599 $664,000
Q4 2019 Feb 14, 2020	BUY	$8.11 - $14.65 $52,771 - $95,327	6,507 Added 17.29%	44,143 $579,000
Q2 2019 Aug 13, 2019	BUY	$8.51 - $10.75 $114,323 - $144,415	13,434 Added 55.51%	37,636 $371,000
Q1 2019 May 13, 2019	BUY	$6.39 - $10.42 $76,398 - $124,581	11,956 Added 97.63%	24,202 $246,000
Q4 2018 Feb 12, 2019	BUY	$5.61 - $12.62 $10,928 - $24,583	1,948 Added 18.92%	12,246 $77,000
Q3 2018 Nov 14, 2018	BUY	$9.0 - $14.9 $92,682 - $153,440	10,298 New	10,298 $136,000

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Xenon Pharmaceuticals Inc. Transaction History